Biotech · Private company
BeyondSpring Pharmaceuticals Inc.
Track this companyFree. Adds BeyondSpring Pharmaceuticals Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials61 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Docetaxel (D)Phase 3 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Docetaxel + Plinabulin (DP)Phase 3 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- PegfilgrastimPhase 3 · Chemotherapy-induced NeutropeniaClinicalTrials.gov · fetched Nov 12, 2026
- PlinabulinPhase 3 · Chemotherapy-induced NeutropeniaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT)PHASE2 · ACTIVE_NOT_RECRUITING · started Dec 21, 2021ClinicalTrials.gov NCT05130827 · fetched Nov 12, 2026
- A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung CancerPHASE1_PHASE2 · COMPLETED · started Sep 6, 2018ClinicalTrials.gov NCT03575793 · fetched Nov 12, 2026
- Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3PHASE3 · COMPLETED · started May 29, 2018ClinicalTrials.gov NCT03102606 · fetched Nov 12, 2026
- Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2PHASE2 · COMPLETED · started Apr 5, 2017ClinicalTrials.gov NCT04345900 · fetched Nov 12, 2026
- Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)PHASE1 · COMPLETED · started Aug 29, 2016ClinicalTrials.gov NCT02812667 · fetched Nov 12, 2026
- Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLCPHASE3 · COMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02504489 · fetched Nov 12, 2026